Henry Schein Research and Development Expenses 2010-2025 | HSIC

Henry Schein annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Henry Schein research and development expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Henry Schein research and development expenses for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
  • Henry Schein annual research and development expenses for 2024 were $0B, a 0% decline from 2023.
  • Henry Schein annual research and development expenses for 2023 were $0B, a 0% decline from 2022.
  • Henry Schein annual research and development expenses for 2022 were $0B, a 0% decline from 2021.
Henry Schein Annual Research and Development Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Henry Schein Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.411B $12.673B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.805B 21.44
Becton Dickinson (BDX) United States $51.260B 12.69
Cardinal Health (CAH) United States $38.083B 19.94
Straumann Holding AG (SAUHY) Switzerland $20.857B 0.00
West Pharmaceutical Services (WST) United States $15.151B 31.76
Cooper (COO) United States $14.525B 18.72
Align Technology (ALGN) United States $13.828B 27.45
Merit Medical Systems (MMSI) United States $4.906B 23.72
DENTSPLY SIRONA (XRAY) United States $3.125B 9.33
CONMED (CNMD) United States $1.474B 11.03
STAAR Surgical (STAA) United States $0.860B 0.00
Lifevantage (LFVN) United States $0.163B 16.84
Pro-Dex (PDEX) United States $0.151B 16.50